Showing results (61-70 of 134) with videos related to

Sort By:
Pageof 14
Haematologica|July 6, 2005
New insights into the pathophysiology of gastrointestinal graft-versus-host disease using capsule endoscopyMichael Shapira, Samuel N Adler, Harold Jacob, et al.
American Journal of Blood Research|March 21, 2012
Visualization of immune response kinetics in full allogeneic chimerasGregory Elkin, Tatyana B Prigozhina, Shimon Slavin, et al.
Infectious Disorders Drug Targets|April 20, 2022
A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 PatientsTibor Bakacs, Volker Sandig, Shimon Slavin, et al.
Neuropharmacology|August 24, 2007
Cannabidiol arrests onset of autoimmune diabetes in NOD miceLola Weiss, Michael Zeira, Shoshana Reich, et al.
Stem Cells (Dayton, Ohio)|September 12, 2003
Reconstruction of cartilage, bone, and hematopoietic microenvironment with demineralized bone matrix and bone marrow cellsOlga Gurevitch, Basan Gowda S Kurkalli, Tatyana Prigozhina, et al.
Cancer Immunology, Immunotherapy : CII|June 22, 2010
Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I studyShimon Slavin, Aliza Ackerstein, Reuven Or, et al.
Springer Seminars in Immunopathology|November 19, 2004
Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow productsReuven Or, Memet Aker, Michael Yechiel Shapira, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Depletion of alloantigen-primed lymphocytes overcomes resistance to allogeneic bone marrow in mildly conditioned recipientsTatyana B Prigozhina, Gregory Elkin, Olga Gurevitch, et al.
Annals of Medicine|September 14, 2007
Hematopoietic stem cell therapy for malignant diseasesMichael Y Shapira, Ali Abdul Hai, Panagiotis Tsirigotis, et al.
Cancer Research|November 4, 2005
Induction of early post-transplant graft-versus-leukemia effects using intentionally mismatched donor lymphocytes and elimination of alloantigen-primed donor lymphocytes for prevention of graft-versus-host diseaseIris Yang, Iris Yung, Lola Weiss, et al.
Pageof 14